Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Vous n'êtes pas connecté
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania published this week in JAMA Internal Medicine.
Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons...
Semaglutide, a medlinkweight loss/medlink medication, did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior....
TUESDAY, Sept. 3, 2024 -- Treatment with semaglutide does not increase the risk for developing symptoms of depression or suicidal ideation/behavior...
Semaglutide's safety for mental health with FDA evaluations shows no increased risk of depression or suicidal thoughts.
Semaglutide's safety for mental health with FDA evaluations shows no increased risk of depression or suicidal thoughts.
Highlights: Semaglutide drugs linked to a higher risk of suicidal thoughts, especially with psychiatric medications
Recent studies suggest a potential link between semaglutide-based medications, such as Ozempic, and an increased risk of suicidal thoughts.
Recent studies suggest a potential link between semaglutide-based medications, such as Ozempic, and an increased risk of suicidal thoughts.
WEDNESDAY, Sept. 11, 2024 -- The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers...
TUESDAY, Sept. 3, 2024 -- The booming popularity of the weight-loss drug semaglutide has prompted increasing concerns about potential side effects...